Catcher Technology, a prominent metal casing manufacturer and former Apple supplier, announced yesterday an investment of up to $20 million (approx. NT$628 million) to acquire Series C preferred shares of Niche Biomedical.

• Investment Details: Catcher will acquire up to 14.84 million shares, representing a maximum stake of 22.2%.
• Diversification Strategy: This move is part of Catcher’s broader transition since exiting the iPhone casing supply chain in 2020. The company is aggressively diversifying into high-margin sectors, specifically targeting the neuromodulation medical device market, alongside its interests in semiconductor and aerospace components.

Resource: 可成入股Niche Biomedical 布局神經調控醫材